1. Risk assessment of 2β,3β-19α-trihydroxyursolic acid from Rubus imperialis (Rosaceae) in HepG2/C3A cells via genotoxicity, metabolism, and cell growth.
- Author
-
Oshiiwa B, da Silva AP, Alves GR, Filho VC, Niero R, O'Neill de Mascarenhas Gaivão I, de Oliveira LM, de Lima LVA, Mantovani MS, and Maistro EL
- Subjects
- Humans, Hep G2 Cells, Risk Assessment, Apoptosis drug effects, Cytochrome P-450 CYP3A genetics, Cytochrome P-450 CYP3A metabolism, Triterpenes pharmacology, Triterpenes toxicity, Plant Extracts toxicity, Plant Extracts pharmacology, Cell Cycle drug effects, Cyclin-Dependent Kinase Inhibitor p21 genetics, Cyclin-Dependent Kinase Inhibitor p21 metabolism, Cell Survival drug effects, DNA Damage drug effects, Cell Proliferation drug effects, Rubus chemistry
- Abstract
Rubus imperialis (Rosaceae) is a Brazilian medicinal plant that already exhibited therapeutical perspectives. However, previous studies revealed cellular and/or genetic toxicity of extracts from aerial parts of this plant, as well as other species of the Rubus genus. Being 2β,3β-19α-trihydroxyursolic acid (2B) one of the major compounds of this plant, with proven pharmacological effect, it is important to investigate the biosafety of this isolated compound. Therefore, in the present study, (2B) was tested by several cytogenotoxic endpoints up to 20 μg/ml in human hepatoma HepG2/C3A cells. The test compound did not produce any decreased cell viability, DNA damage, chromosomal mutations, cell cycle changes, or apoptotic effects in the tested cells. Additionally, RT-qPCR analysis revealed the downregulation of CYP3A4 (metabolism), M-TOR (cell death), and CDKN1A (cell cycle) genes. Under the experimental conditions used, the 2B compound did not show cytogenotoxic activity after a single exposure to HepG2/C3A human cells., (© 2024 John Wiley & Sons, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF